Loading Curie Briefs...
Getting the latest healthcare news for you
Getting the latest healthcare news for you
Metabolic conditions are common in chronic rhinosinusitis patients — but so is everyone else. A large meta-analysis of over 1.1 million adults found that rates of obesity, hypertension, dyslipidemia, and diabetes in CRS patients are broadly similar to global population estimates. Notably, CRS patients actually had lower odds of elevated total cholesterol compared to those without the condition.
Chronic rhinosinusitis (CRS) patients carry a notable burden of metabolic conditions — but a new meta-analysis suggests this isn't unique to the disease itself. Researchers analyzed 53 studies covering more than 1.1 million adults with CRS and found that the prevalence of obesity, hypertension, dyslipidemia, and diabetes was broadly in line with global reference estimates, not elevated above them.
One finding stood out: CRS patients had lower odds of elevated total cholesterol (>240 mg/dL) compared to people without CRS. Meanwhile, odds of diabetes and hypertension were statistically comparable between the two groups — suggesting CRS doesn't independently drive metabolic risk.
By the Numbers:
Why it matters: Clinicians may wonder whether CRS warrants extra metabolic screening. This study says: not necessarily. Standard guideline-based cardiometabolic care is sufficient for this population — no need for additional routine metabolic workups beyond what's already recommended.
